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Upper extremity peripheral neuropathies: role
and impact of MR imaging on patient
management
Abstract To investigate the role of
MR imaging (MRI) in the evaluation
of peripheral nerve lesions of the
upper extremities and to assess its
impact on the patient management.
Fifty-one patients with clinical evi-
dence of radial, median, and/or ulnar
nerve lesions and unclear or ambig-
uous clinical findings had MRI of the
upper extremity at 1.5 T. MR images
and clinical data were reviewed by
two blinded radiologists and a group
of three clinical experts, respectively,
with regard to radial, median, and/or
ulnar nerve, as well as muscle ab-
normalities. MRI and clinical findings
were correlated using Spearman’s (p)
rank correlation test. The impact of
MRI on patient management was
assessed by the group of experts and
ranked as “major,” “moderate,” or
“no” impact. The correlation of MRI
and clinical findings was moderate for
the assessment of the median/radial
nerve and muscles (p=0.51/0.51/0.63,
respectively) and weak for the ulnar
nerve (p=0.40). The impact of MRI
on patient management was assessed
as “major” in 24/51 (47%), “moder-
ate” in 19/51 (37%), and “no” in 8/51
(16%) patients. MRI in patients with
upper extremity peripheral neuropa-
thies and unclear or ambiguous clin-
ical findings substantially influences
the patient management.
Keywords Peripheral nervous
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Introduction
The evaluation of peripheral nerve lesions of the upper
extremities has traditionally relied on information from an
accurate clinical history, a thorough physical examination
and electro-diagnostic testing [1]. In most of the patients,
these clinical data allow for the determination of location,
severity, as well as the etiology of the underlying nerve
injury [2].
However, all this clinical information is sometimes
insufficient in order to establish the exact diagnosis or with
regard to tailoring the treatment for patients with a
peripheral nerve lesion. In clinical practice, the localization
of a nerve lesion in the absence of abnormal electro-
diagnostic findings or diagnosing a focal entrapment
neuropathy superimposed on a more general peripheral
neuropathy may be challenging [1]. Moreover, clinical
information including electro-diagnostic studies may also
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be insufficient for determining resectability of a peripheral
nerve mass.
Over the past few years, MR imaging (MRI) has gained
increased acceptance as a non-invasive diagnostic adjunct
to the clinical evaluation of patients with peripheral nerve
lesions [2]. State-of-the-art MRI is not only able to
visualize a variety of abnormalities of the nerve itself, but
is also useful for the demonstration of denervation changes
of the innervated muscles [3, 4]. Recently, it has been
shown that MR signal changes in denervated muscles can
be used to diagnose peripheral nerve lesions and may even
be as accurate as electro-diagnostic examination [5].
Several studies have described typical MRI findings in
peripheral nerve lesions of the upper extremities, such as
the findings in virgin and recurrent carpal tunnel syndrome
[6, 7], compressive and entrapment neuropathies of the
median, ulnar, and radial nerve at the elbow and at the wrist
[8–11], as well in neuropathies of the suprascapular, long
thoracic, musculocutaneus, and axillary nerve [12, 13]. In
addition, MRI characteristics of various peripheral nerve
tumor masses have been reported [14–16]. Although the
MRI findings of these entities are well described, the role
of MRI in the evaluation of peripheral nerve lesions
remains unclear, especially with regard to the impact of
MRI on patient management [14, 17].
Hence, the purpose of our paper was to investigate the
role of MRI in the evaluation of peripheral nerve lesions of
the upper extremities and to assess the impact of MRI on
patient management.
Materials and methods
Subjects
The local institutional review board approved this study,
which was performed in a retrospective manner with
written informed patient consent for the retrospective
review of clinical and MRI data.
In this study, we included only patients with clinically
evident neuropathies of the radial, median, and/or ulnar
nerve. Eight hundred and forty-eight cross-reference
records of the departments of surgery (division of hand
and plastic surgery) and the department of radiology from
2003 to 2006 were reviewed. We identified 51 patients who
were referred to our institution for MRI of an upper
extremity (MRI of the shoulder/axilla, upper arm, elbow,
forearm, wrist, and/or hand) with clinical evidence of a
lesion on at least one of the aforementioned nerves and in
whom clinical findings were ambiguous or in whom final
diagnosis remained unclear. We defined “unclear” or
“ambiguous” when after a clinical evaluation, including
thorough electro-diagnostic testing, from a clinical point of
view, the etiology, the exact anatomic location, the number
of the lesions (single vs. multiple lesions causing the nerve
injury) was uncertain, or when there was a discrepancy
between the symptoms and the clinical findings. Patients
were only included when their charts contained complete
clinical information including all “pre-MRI” clinical data
(clinical history, physical and electrodiagnostic examina-
tion), the original MRI report as well as all clinical “post-
MRI” data (treatment plan, surgical report, follow-up data).
Patients with signs of central nervous system abnorm-
alities, lower cervical radiculopathy, and lower trunk
brachial plexopathy were excluded. Patients with abnorm-
alities of the suprascapular, long thoracic, musculocuta-
neus, or axillary nerve were not included in this study.
Patients with symptoms of carpal tunnel syndrome were
only included if their symptoms were not sufficiently
explained by the clinical findings. Patients with carpal
tunnel syndrome usually do not routinely have MRI in our
institution unless there is a discrepancy between symptoms
and clinical findings. We also did not include patients with
acute traumatic peripheral nerve lesions. All patients were
referred from a team of two hand surgeons and two
specialized neurologists.
The mean age of the 51 patients (female, 29; male, 22)
was 42.7 years (age range, 18 to 80 years). In these 51
patients, a total of 51 MR examinations were performed
(28 right upper extremities, 23 left upper extremities). In all
patients only one anatomical region per extremity was
examined.
MRI technique
All MRI examinations were performed on one of two 1.5-T
MR systems [Signa Horizon Signa Excite II Echo Speed
Plus or Signa Echospeed HD; General Electrics (GE)
Healthcare Systems, Waukesha, WI]. Among the 51
patients with 51 MR examinations, 1 MR examination of
the shoulder/axilla (2%), 2 MR examinations of the upper
arm (4%), 9 MR examinations of the elbow (18%), 18 MR
examinations of the forearm (35%), and 21 MR examina-
tions of the wrist and hand (41%) were performed.
According to the anatomic region of interest, the upper
extremity was positioned in a neutral position in the center
of the corresponding custom-designed coil, which was
placed in the isocenter of the magnet. A phased array
shoulder coil (Medical Advances Inc., Milwaukee, WI) or
an eight-channel torso-pelvic coil (GE) was applied for
imaging the shoulder/axilla region. A cardiac coil with a
four- or eight-channel design (GE) was used for the upper
arm and elbow. An extremity array coil (Medrad Inc.,
Indianola, PA) was applied for the forearm and hand. MRI
of the wrist was performed using a high-resolution wrist
coil (MRI Devices Corp., Orlando, FL). T1-, T2-, and
intermediate-weighted spin echo (SE) or fast spin echo
(FSE) as well as T1-weighted short spoiled gradient
recalled echo pulse (SSPGR) and short tau inversion
recovery (STIR) sequences were acquired in each anatomic
region in all three planes. Sequence parameters included
1954
TR 197–4,840 ms, TE 9–110 ms, TI 150 ms (for STIR
sequences), and an echo train length of 8 (for FSE
sequences). In addition, a three-dimensional (3D) gradient
echo (GRE) sequence (TR/TE 20/12 ms, flip angle 20) was
acquired in the hands and wrists. Other parameters
included: section thickness 1.3 to 4.0 mm, intersection
gap 0.3 to 1.0 mm, acquisition matrix 256–512×192–256,
field of view 12–30×12–30, and numbers of excitations
2–4. Contrast enhanced T1-weighted fat saturated SE or
SSPGR sequences were acquired after intravenous admin-
istration of 0.1 mMol/kg body weight of Gd-DTPA
(Magnevist®; Schering AG, Berlin, Germany) in all
patients. All sequences were used for retrospective MRI
analysis.
Clinical data
Before the MRI referral, all 51 patients had a detailed
clinical and neurological examination including electro-
diagnostic examinations of the radial, median, and ulnar
nerve by one of two experienced hand surgeons and by one
of two specialized neurologists, respectively. Standard
fine-needle electromyography of individual muscles was
used in cases with clinical evidence of a muscle abnor-
mality [1]. All electro-diagnostic studies were performed
according to the consensus criteria of the American
Association of Electro-Diagnostic Medicine (AAEM) [1]
and the results were thoroughly recorded in the patient’s
charts.
MRI analysis
Two blinded radiologists (G.A.; D.W.) analyzed retro-
spectively all MR images independently and in a random
order. Imaging analysis was performed on a separate
workstation (Advantage Windows 4.2; GE).
First, all MR images were evaluated with regard to
radial, median, and/or ulnar nerve abnormalities. To
facilitate a direct correlation of MRI and clinical findings
(see below), we selected a simple binary classification
system (adapted from Jarvik et al. [18]): 0=normal nerve
(normal nerve signal, absence of thinning/thickening, or
external nerve compression); 1=abnormal nerve (abnormal
nerve signal, presence of thinning/thickening, external
nerve compression, or a mass lesion).
Second, both observers noted all muscle abnormalities,
again using a simple binary classification system: 0=
normal muscle (normal muscle signal, absence of muscle
atrophy); 1=abnormal muscle (“muscle edema”, presence
of muscle atrophy). “Muscle edema” was presumed in the
event of high MR signal on T2-weighted or STIR MR
images [19]. The MR signal for muscles was considered
normal if it was generally much lower than that of fat,
slightly higher than that of water on T1-weighted images,
and much lower than that of both fat and water on T2-
weighted images. On STIR MR images, normal muscle
signal intensity should be higher than that of fat, but much
lower than that of water. Muscle atrophy was defined as
followed: moderate muscle atrophy = significant loss of
muscle volume (<50% of normal muscle volume); severe
muscle atrophy = presence of fatty degeneration with
>50% loss of normal muscle volume [20, 21].
Third, both observers had to decide, in cases with the
presence of a muscle abnormality, whether it was caused by
a myogenic (i.e., the abnormality is caused by a primary
affection of the muscle, no specific pattern of involved
muscles) or either a neurogenic etiology (i.e., the abnor-
mality is caused by an affection or lesion of the nerve,
specific pattern of involved muscles according to their
innervations). Fourth, each observer was asked whether the
abnormalities could represent either an “acute” (<4 weeks),
“subacute” (4 weeks to 1 year), or “chronic” disorder
(>1 year). Acute neurogenic muscle disorders may show
muscle edema without muscle atrophy, whereas chronic
muscle disorders may show muscle atrophy without
muscle edema. “Subacute” defines the time range between
4 weeks and 1 year in duration [4, 22] and may be
characterized by muscle edema and muscle atrophy at the
same time.
Finally, each observer was asked to make a final MR
diagnosis based on MRI findings with regard to the
location and the underlying etiology of the peripheral nerve
lesion.
Clinical correlation and assessment of the impact
of MRI on further patient management
Figure 1 illustrates the different steps of the clinical data
analysis (Fig. 1), which were organized by the study
coordinator (G.A.). Clinical data analysis was performed
by a panel of clinical experts (one hand surgeon and two
neurologists). In the first step, the study coordinator
presented all clinical data from the patient’s charts
(including clinical history, physical and electro-diagnostic
examination) to the clinical experts as far as these
examinations were performed prior to MRI (“pre-MRI”
clinical data). This means that at step 1 of the review
process, the clinical experts were blinded to the original
MRI report as well as to all other “post-MRI” clinical data.
During this first step, the clinical experts were asked
which of the nerves were affected by the abnormality as
well as the presumed location of the abnormality with
regard to its anatomical course. For grading nerve and
muscle abnormalities, the clinical experts used the same
binary classification system that was used by the radiol-
ogist to classify nerves and muscle on MR images (0=
normal/1=abnormal nerve and muscle, respectively). In
addition, all clinically present or suspected muscle
abnormalities were further classified as “myogenic” or
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“neurogenic.” All abnormalities were assigned as an
“acute,” “subacute,” or “chronic” disorder according to
the aforementioned definitions of these periods. Finally,
based on the “pre-MRI” clinical data, the clinical experts
were asked to set a final “clinical diagnosis” for the
location and the underlying etiology of the peripheral nerve
lesion. The results of this first step of the review process
were used for the subsequent correlation of clinical data
with the MRI findings (Fig. 1).
The purpose of the second step of the review process was
to assess the impact of MRI on the patient management
based on all available clinical data. As a difference to step
1, at this time, the results of the original MRI report and all
other “post-MRI” clinical data, including surgical reports
and follow-up data, were made available from the patient
chart by the study coordinator. The clinical experts noted if
the MR examination provided additional information that
helped in establishing the final diagnosis (this was called
“moderate impact”), or if the MR examination changed the
therapeutic considerations, influenced the decision to
perform surgery and/or helped in planning the surgery
(this was called “major impact”).
Statistical analysis
The interobserver agreement between both radiologists with
regard to the MRI analysis was calculated by using the κ
statistics (Fig. 1). Negative kappa values express discordance
of the observations. Kappa values between 0.41 and 0.60
correspond to a moderate agreement, between 0.61 and 0.80
to a substantial agreement, and values higher than 0.80 are
considered as excellent interobserver agreement [23].
The correlation of clinical and MRI findings was
calculated by using Spearman’s (p) rank correlation test.
Absolute p values between 0.5<p<0.8 indicate a moderate
strength of correlation, whereas p>0.8 is considered as
strong to perfect correlation [24].
Cross table calculations were performed to provide
information about the impact of MRI on the patient
management as noted with regard to the different causes of
the peripheral neuropathies, namely “mass lesions,”
“entrapment,” and “post-trauma/inflammatory conditions.”
The Kruskal-Wallis test was used to determine if there is a
significant difference between these three groups with
regard to the impact of MRI on treatment [25].
Statistical analysis and a descriptive analysis were
performed by using dedicated software (SPSS, release
11.5, SPSS Inc.; Chicago, IL).
Results
Clinical findings
The primary reasons for referring the patients for MRI were
an unclear etiology [28 of 51 patients (55%) (Figs. 2 and 3)],
an unclear site in respect to the exact anatomic localization, or
number of the lesions (i.e., single vs. multiple lesions causing
the nerve injury), 7 of 51 patients (14%); both unclear, the
etiologies and the site/exact anatomic localization/numbers of
the lesions, 16 of 51 patients (31%).
Fig. 1 Diagram illustrates the
different steps of data analysis.
MR imaging (MRI) data were
retrospectively analyzed by two
blinded radiologists indepen-
dently. Interobserver agreement
was calculated. Radiological
findings were correlated with
clinical findings, which were
retrospectively analyzed by a
panel of experts. The impact of
MRI on the patient management
was assessed by the same panel
experts’ based on all clinical
findings as documented in the
patient charts
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Table 1 shows a summary of the clinical findings in all
51 patients with a clinically evident abnormality of the
median, ulnar, and/or radial nerve (step 1 of the clinical
data analysis). In all patients, at least one of the
aforementioned nerves was affected. Affections of two or
all three nerves were seen in 8 of 51 patients (16%). Table 2
provides an overview of the final diagnoses as documented
in the patient’s charts.
MRI findings and clinical correlation
The MRI findings of 51 patients with a clinically evident
abnormality of the median, ulnar, and/or radial nerve are
shown in Table 1. Based on MRI findings, nerve
abnormalities affecting two or all three aforementioned
nerves were present in 6 of 51 patients (12%).
Overall, the agreement between both radiologists for
MRI analysis was substantial to perfect (κ=0.74 to 1.0).
Detailed kappa values are given as follows: grading of the
median nerve, excellent agreement (κ=1.0); grading of the
ulnar nerve, excellent agreement (κ=0.96); grading of
the radial nerve, excellent agreement (κ=0.91); overall
muscle grading, excellent agreement (κ=0.88); presence/
absence of muscle atrophy, substantial agreement (κ=
0.74); presence/absence of muscle edema, excellent
agreement (κ=1.0); etiology of muscle abnormality,
excellent agreement (κ=0.90); stage of disorder (acute
vs. chronic), excellent agreement (κ=0.94).
MRI was able to detect the etiology of nerve disorders in
26 of the 28 patients (93%) who were referred for MRI with
an unclear etiology. MRI revealed the site, exact anatomic
Fig. 2 A 27-year-old female patient with weakness of the extensor
muscles of the hand. Axial T1-weighted SE (TR/TE; 400/14 ms) (a)
and corresponding short tau inversion recovery (STIR) (TR/TE,
4,840/55 ms; TI, 150 ms) (b) MR image at the level of the proximal
forearm shows a loss of muscle volume (a) [supinator muscle (m).,
1; extensor pollicis brevis and longus m., 2; extensor digitorum,
digiti minimi and carpi ulnaris m., 3] and depicts muscle edema (b).
Due to the pattern of muscle involvement (all muscles affected are
innervated by the posterior interosseous nerve) with synchronic
muscle edema and atrophy, both radiologists diagnosed a subacute
posterior interosseous nerve syndrome (PINS) when retrospectively
reviewing the MRI data. This radiological diagnosis was identical
with the final diagnosis, as documented in the patient chart after
surgery
Fig. 3 A 45-year-old male patient with clinical evidence of carpal
tunnel syndrome of unknown etiology. Axial T1-weighted SE (TR/
TE 500/9 ms) (a) and corresponding fat-suppressed coronal T2-
weighted fast spin echo (FSE) (TR/TE, 3,460/110 ms) (b) MR
image at the level of the metacarpal bones. Based on the MRI
findings of a gross enlargement of the median nerve with a
fascicular pattern and fibroadipose tissue (arrowhead) between the
individual nerve fascicles (arrow), both radiologists diagnosed a
fibrolipomatous hamartoma of the median nerve when retrospec-
tively reviewing the MRI data. This radiological diagnosis was
identical with the final diagnosis, as documented in the patient chart
after surgery
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localization or the number of the lesions (i.e., single vs.
multiple lesions causing the nerve injury) in all seven
patients (100%) in whom the data were unclear before the
MR examination. MRI detected multiple lesions in one of
these seven patients (14%). In those 16 patients in whom
both the etiologies as well as the site/exact anatomic
localization/number of the lesions were unclear prior to
MRI, MRI showed either the etiology or the site/exact
anatomic localization/number of lesions in 13 patients
(82%). In only 3 of 51 patients (6%), no additional
information was derived from MRI.
Clinical and radiological findings showed a weak to
moderate correlation (p=0.48 to 0.63) (Table 1).
Impact on patient management
The impact of MRI on the patient management was described
as a “major impact” in 24 of 51 patients (47%, Fig. 4) and as
“moderate impact” in 19 of 51 patients (37%). In 8 of 51
patients (16%), there was “no impact” of MRI on patient
management. A sub-analysis (Table 3) with respect to the
impact ofMRI on patient management and different causes of
neuropathies (“mass lesions,” “entrapment” and “post-trauma/
inflammatory conditions”) showed no significant difference
(Kruskal-Wallis test, p=0.56) among these three groups.
Discussion
Our study illustrates the role of MRI in the evaluation of
upper extremity peripheral nerve lesions, which is not well
Table 1 Clinical findings, MR imaging findings, and correlation of
clinical and MR imaging findings in 51 patients with a clinically
evident abnormality of the median, ulnar, and/or radial nerve
Clinical findings
no. (%)
MR imaging
findings no. (%)
Correlation
(p)
Nerves
Median nerve
Normal 22 (43) 35 (69) 0.51
Abnormal 27 (57) 16 (31)
Ulnar nerve
Normal 32 (63) 34 (67) 0.40
Abnormal 19 (37) 17 (33)
Radial nerve
Normal 42 (82) 43 (84) 0.51
Abnormal 9 (18) 8 (16)
Muscles
Normal
muscles
29 (57) 28 (55) 0.63
Abnormal
muscles
22 (43) 23 (45)
Atrophy
Moderate 9 (17) 5 (10) 0.59
Severe 15 (29) 12 (29)
Muscle
function
Weakness1 32 (63) n.a. n.a.
EMG2 20 (39) n.a.
Edema
T2w images n.a. 19 (37) n.a.
Etiology
Myogenic 1 (2) 3 (6) 0.48
Neurogenic 20 (39) 20 (39)
Stage of
disorder
Acute 9 (17) 5 (9) 0.48
Subacute 10 (19) 8 (16)
Chronic 13 (25) 10 (20)
Data are presented as sum of cases (no.). Numbers of cases are also
expressed as percentage of all 51 cases, calculated as follows:
percentage % = (no./51) * 100. 1Presence of muscle weakness,
graded according to the British Medical Research Council (BMC)
grading system; 2 presence of muscle denervation signs
(including fibrillation potentials and positive sharp waves) at
fine-needle electromyogram; n.a. = not applicable; T2w = T2-
weighted
Table 2 Final diagnosis (as documented in the patient charts) in 51
patients with a clinically evident abnormality of the median, ulnar
and/or radial nerve
Diagnosis No. (%)
Mass lesions (n=29)
Neurofibroma 8 (16)
Fibrolipomatous hamartoma 6 (12)
Schwannoma 2 (4)
Nerve sheet ganglia 2 (4)
Neurosarkoma 1 (2)
Entrapment (n=25)
Anterior interosseus nerve syndrome 5 (10)
Posterior interosseus nerve (supinator) syndrome 5 (10)
Cubital tunnel syndrome 7 (13)
Carpal tunnel syndrome 4 (8)
Guyon canal syndrome 2 (4)
Pronator syndrome 1 (2)
External compression due to lipoma 1 (2)
Post-trauma/inflammatory conditions (n=7)
Scarring 3 (6)
Multifocal motor neuropathy (MMN) 2 (4)
Polyneuropathies 2 (4)
Data are presented as sum of cases (no.). Numbers of cases are also
expressed as percentage of all 51 cases, calculated as follows:
percentage % = (no./51) *100
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established in literature. Although there is generally
consensus that the diagnosis of a peripheral neuropathy is
commonly based on clinical and electrodiagnostic studies,
some recent articles have shown that MRI may be helpful
in establishing the diagnosis [10, 26] or may guide further
patient management in cases where the clinical findings are
unclear or ambiguous [27, 28].
Our MRI protocols are mainly focused on the assessment
of morphological criteria and do not include functional
MRI techniques. When reviewing the literature with regard
to MRI of upper extremity peripheral neuropathies, most
publications are also focused on the morphological appear-
ance of those neuropathies [6, 9, 11, 13, 17]. We found only
a few recent experimental studies that also addressed the
potential of advanced techniques for peripheral nerve
imaging including diffusion-direction-dependent (DDI)
MRI [29] as well the use of newer MR contrast agents
[such as superparamagnetic iron oxide (SPIO) particles or
gadofluorine M] [30, 31]. However, regardless the imaging
protocols used, to the best of our knowledge, none of these
studies systematically evaluated the role of MRI and its
impact on patient management in upper extremity periph-
eral neuropathies.
The correlation between clinical findings and MRI in
patients with peripheral neuropathies is difficult. In a
prospective study by Jarvik et al. on patients with suspected
carpal tunnel syndrome (CTS), MRI revealed only a 39%
specificity when compared to clinical examinations
including electrodiagnostic studies [18]. In our study,
which not only focused on CTS but included a broad
variety of upper extremity peripheral neuropathies, we
found a weak or moderate correlation between MRI and the
clinical findings. The correlation was particularly weak
where only direct signs of nerve abnormalities, such as
nerve thickening or high signal intensity, were evaluated
with MRI. The correlation improved when secondary signs
of peripheral neuropathies, such as neurogenic muscle
edema and atrophy, were included in the imaging analysis.
A weak or moderate correlation between clinical and
MRI findings may not be surprising since MRI and clinical
examinations evaluate different aspects of the nerve
disturbance. Clinical evaluations mostly address nerve
function, while MRI evaluations primarily rely on
morphologic criteria. This may explain why most patients
are referred for a MRI only when additional anatomic
imaging is needed [27], e.g., to reveal a mass, or when
clinical findings are ambiguous or unclear [28].
Fig. 4 A 43-year-old male patient who had a motorcycle accident 8
months ago with resulting chronic elbow pain, hand muscle
weakness, and a normal electrodiagnostic ulnar nerve test. (a, b)
Axial T1-weighted SE (TR/TE, 560/9 ms) (a) and corresponding
STIR (TR/TE, 4,580/35 ms; TI, 150 ms) (b) MR images at the level
of the elbow reveal a bone fragment (Fr) and increased signal
intensity at the medial aspect of the elbow (H=humerus; O=
olecranon). (c) Thin-slice maximum intensity projection (MIP)
image created from the STIR MR data set shows a multi-lobulated
mass (asterisks) and an increased signal intensity of the ulnar nerve
(arrows). Based on the MRI findings, both radiologists diagnosed a
focal ulnar neuritis, a ganglion, and a bone fragment when
retrospectively reviewing the MRI data. This radiological diagnosis
was identical with the final diagnosis, as documented in the patient
chart after surgery
Table 3 Impact of MRI on patient management in 51 patients with
a clinically evident abnormality of the median, ulnar, and/or radial
nerve–cross table calculation
(n=51) Mass lesions
(n=19)
Entrapment
(n=25)
Post-trauma/
inflammatory
conditions (n=7)
Major impact
n=24 8 13 3
Moderate impact
n=19 4 10 2
No impact
n=7 4 2 2
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Another reason to use MRI in patients with peripheral
neuropathies is the potential to serve as an adjunct in the
diagnosis and management of these patients. In a series of
12 patients with ulnar nerve entrapment at the level of the
elbow, Britz et al. reported that MRI was able to detect two
or more neuropathies in patients who had normal
electrodiagnostic examinations [32]. In another study by
Grant et al., MRI was found to be more sensitive in
identifying pathologies of the ulnar nerve at the elbow
when compared to pre- or intraoperative electrodiagnostic
studies [33].
In our selected group of patients with peripheral
neuropathies of the upper extremity, we found that in
84% of all patients referred with unclear or ambiguous
findings, MRI had a “moderate” or “major” impact on
therapy. In almost half of the patients, the therapy plan was
changed after the MRI, and in the remaining patients, MRI
revealed important information that was used for further
treatment, such as the planning the duration of conservative
treatment and/or physiotherapy. In only 8/51 patients
(16%), the information derived from MRI was not
considered as helpful for further patient management.
When grouping the patients according to the different
causes of peripheral neuropathies (mass lesions, entrap-
ment, and post-trauma/inflammatory conditions), the im-
pact of MRI on the patient management was the same with
no statistically significant differences between these
groups.
In the future, it may be hypothesized that MRI may also
help to predict which patients respond best to medical or
surgical treatment. However, additional work is necessary
to prospectively determine the ability of MRI to select
patients who will or will not benefit from either treatment.
We acknowledge several limitations of this study. The
study was performed in a retrospective manner in a highly
selected group of patients referred from very experienced
clinicians. Since many of the patients were treated
conservatively, there was no definite standard of reference.
Another limitation may relate to the fact that the clinicians
in the panel who performed the retrospective analysis were
also the referring physicians.
In conclusion, this study demonstrates that MRI in
patients with upper extremity peripheral neuropathies and
unclear or ambiguous findings in clinical examinations
influences the patient management in a substantial
percentage of cases.
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